
Chinese General Practice ›› 2025, Vol. 28 ›› Issue (09): 1156-1160.DOI: 10.12114/j.issn.1007-9572.2024.0342
Special Issue: 内分泌代谢性疾病最新文章合辑
• Frontiers of Medicine • Previous Articles
Received:2024-05-10
Revised:2024-09-10
Published:2025-03-20
Online:2025-01-02
Contact:
WU Biaoliang
通讯作者:
吴标良
作者简介:作者贡献:
岑妮秒负责查阅文献、文章的构思与设计,论文撰写;韦云师、黄丽娜负责论文修订;吴标良负责论文修订与审校,最终版本修订,对论文负责。
基金资助:CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0342
| 外泌体来源 | miRNA | 糖尿病创面水平变化 | 靶基因 | 作用机制 | 文献 |
|---|---|---|---|---|---|
| 糖尿病患者血浆 | miR-20b-5p | ↑ | Wnt9b | 通过调控Wnt9b信号传导抑制人脐静脉内皮细胞功能和血管生成 | [ |
| 人血清 | miR-24-3p | ↑ | PIK3R3 | 通过降低PIK3R3表达,抑制内皮细胞功能 | [ |
| DFU患者外周血 | miR-15a-3p | ↑ | NOX5 | 通过下调NOX5表达,进而抑制内皮细胞功能 | [ |
| 牛奶 | miR-31-5p | ↓ | HIF1AN | 牛奶外泌体介导的miR-31-5p通过下调HIF1AN的表达,显著改善了内皮细胞功能 | [ |
| DFU创面渗液 | miR-195-5p、miR-205-5p | ↑ | VEGF-A | 通过抑制VEGF-A的表达,减少血管生成 | [ |
| 人间充质干细胞 | miR-205-5p | ↑ | VEGF | 通过抑制VEGF的蛋白质翻译,阻碍新生血管形成 | [ |
| 人骨髓间充质干细胞 | miR-21-5p | ↓ | VEGFR | 通过上调VEGFR以及激活AKT和MAPK信号通路来促进血管生成 | [ |
| 内皮祖细胞 | miR-221-3p | ↓ | VEGF、CD31、Ki67 | 通过增加VEGF、CD31、Ki67蛋白表达水平,促进新生血管生成 | [ |
| 小鼠间充质干细胞 | miR-23a、miR-125b | ↓ | TLR4、NF-κB | 通过协同抑制TLR4/NF-κB信号通路促进炎症巨噬细胞M1表型转化为M2表型,显著降低促炎细胞因子水平 | [ |
| 脂肪干细胞 | miR-125b | ↓ | TLR4、IL-6 | 通过降低炎症相关蛋白TLR-4和IL-6的表达,减少炎症浸润 | [ |
| 小鼠骨髓间充质干细胞 | miR-146a | ↓ | IRAK-1、TRAF-6、NF-κB | 通过下调IRAK-1、TRAF-6和NF-κB的表达,减弱创面炎症反应 | [ |
| 小鼠脂肪干细胞 | miR-132 | ↓ | 磷酸化p65和IκB | 通过下调磷酸化p65和IκB的表达,从而抑制NF-κB信号通路,诱导M2型巨噬细胞计划,从而进一步创面减轻炎症反应 | [ |
| 骨髓间充质干细胞 | miR-155 | ↑ | FGF-7 | 抑制骨髓间充质干细胞外泌体miR-155可促进FGF-7蛋白表达,增强角质形成细胞增迁移和再上皮化 | [ |
| 骨髓间充质干细胞 | miR-4645-5p | ↓ | MAPKAPK2 | 通过靶向MAPKAPK2诱导AKT-mTORC1信号失活,激活角质形成细胞自噬、增殖和迁移 | [ |
| 脐静脉内皮细胞 | miR-106b-5p | ↓ | ERK1/2 | 通过下调ERK1/2表达,激活成纤维细胞自噬,抑制胶原合成,延迟糖尿病大鼠的伤口愈合过程 | [ |
| 脂肪间充质干细胞 | miR-128-1-5p | ↓ | TGF-β1、α-SMA | 通过下调TGF-β1/Smad信号通路促进糖尿病大鼠创面愈合,并抑制皮肤纤维化 | [ |
Table 1 Effect and mechanism of exosomal miRNA on diabetic ulcer wounds
| 外泌体来源 | miRNA | 糖尿病创面水平变化 | 靶基因 | 作用机制 | 文献 |
|---|---|---|---|---|---|
| 糖尿病患者血浆 | miR-20b-5p | ↑ | Wnt9b | 通过调控Wnt9b信号传导抑制人脐静脉内皮细胞功能和血管生成 | [ |
| 人血清 | miR-24-3p | ↑ | PIK3R3 | 通过降低PIK3R3表达,抑制内皮细胞功能 | [ |
| DFU患者外周血 | miR-15a-3p | ↑ | NOX5 | 通过下调NOX5表达,进而抑制内皮细胞功能 | [ |
| 牛奶 | miR-31-5p | ↓ | HIF1AN | 牛奶外泌体介导的miR-31-5p通过下调HIF1AN的表达,显著改善了内皮细胞功能 | [ |
| DFU创面渗液 | miR-195-5p、miR-205-5p | ↑ | VEGF-A | 通过抑制VEGF-A的表达,减少血管生成 | [ |
| 人间充质干细胞 | miR-205-5p | ↑ | VEGF | 通过抑制VEGF的蛋白质翻译,阻碍新生血管形成 | [ |
| 人骨髓间充质干细胞 | miR-21-5p | ↓ | VEGFR | 通过上调VEGFR以及激活AKT和MAPK信号通路来促进血管生成 | [ |
| 内皮祖细胞 | miR-221-3p | ↓ | VEGF、CD31、Ki67 | 通过增加VEGF、CD31、Ki67蛋白表达水平,促进新生血管生成 | [ |
| 小鼠间充质干细胞 | miR-23a、miR-125b | ↓ | TLR4、NF-κB | 通过协同抑制TLR4/NF-κB信号通路促进炎症巨噬细胞M1表型转化为M2表型,显著降低促炎细胞因子水平 | [ |
| 脂肪干细胞 | miR-125b | ↓ | TLR4、IL-6 | 通过降低炎症相关蛋白TLR-4和IL-6的表达,减少炎症浸润 | [ |
| 小鼠骨髓间充质干细胞 | miR-146a | ↓ | IRAK-1、TRAF-6、NF-κB | 通过下调IRAK-1、TRAF-6和NF-κB的表达,减弱创面炎症反应 | [ |
| 小鼠脂肪干细胞 | miR-132 | ↓ | 磷酸化p65和IκB | 通过下调磷酸化p65和IκB的表达,从而抑制NF-κB信号通路,诱导M2型巨噬细胞计划,从而进一步创面减轻炎症反应 | [ |
| 骨髓间充质干细胞 | miR-155 | ↑ | FGF-7 | 抑制骨髓间充质干细胞外泌体miR-155可促进FGF-7蛋白表达,增强角质形成细胞增迁移和再上皮化 | [ |
| 骨髓间充质干细胞 | miR-4645-5p | ↓ | MAPKAPK2 | 通过靶向MAPKAPK2诱导AKT-mTORC1信号失活,激活角质形成细胞自噬、增殖和迁移 | [ |
| 脐静脉内皮细胞 | miR-106b-5p | ↓ | ERK1/2 | 通过下调ERK1/2表达,激活成纤维细胞自噬,抑制胶原合成,延迟糖尿病大鼠的伤口愈合过程 | [ |
| 脂肪间充质干细胞 | miR-128-1-5p | ↓ | TGF-β1、α-SMA | 通过下调TGF-β1/Smad信号通路促进糖尿病大鼠创面愈合,并抑制皮肤纤维化 | [ |
| [1] | |
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
刘贤彬. 血糖对糖尿病创面愈合的作用及糖尿病足预后的影响因素[D]. 右江:右江民族医学院,2020.
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
戚世玲,刘清,何仁亮,等. MEBO联合微粒皮种植对糖尿病足创面组织中VEGF、EGF表达水平的影响[J]. 中国烧伤创疡杂志,2022,34(4):240-243,253. DOI:10.3969/j.issn.1001-0726.2022.04.003.
|
| [27] |
何明杰,甘忠贵,郑爱甜,等. 高压氧对糖尿病足创面组织中VEGF、EGF表达水平的影响[J]. 中国烧伤创疡杂志,2021,33(4):237-242. DOI:10.3969/j.issn.1001-0726.2021.04.003.
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [1] | LI Jing, LIU Ziqi, QIAN Li, YAO Ruiqin. Research Progress on the Role of the Microbiota-gut-brain Axis in Epilepsy [J]. Chinese General Practice, 2026, 29(32): 4821-4826. |
| [2] | WANG Shiyi, FAN Xiaojing, SI Yafei, ZHOU Zhongliang. Advances in Key Measurement Techniques for the Intrinsic Capacity of Elderly in the Context of Healthy Aging [J]. Chinese General Practice, 2026, 29(31): 4662-4666. |
| [3] | HE Yang, YANG Rong, SHEN Can, YI Shanye, LIU Lidi, ZHAO Qian, WAN Zhi, LIAO Xiaoyang. Progress in Research on the Trajectory of Frailty and Its Influencing Factors [J]. Chinese General Practice, 2026, 29(30): 4372-4378. |
| [4] | ZHAO Jiayi, FAN Jian, YU Dehua. The Current Situation, Challenges, and Coping Strategies of Preserving Ratio Impaired Spirometry [J]. Chinese General Practice, 2026, 29(30): 4366-4371. |
| [5] | LI Xiling, ZHANG Fan, YANG Xinyue, YANG Heng. Application of Exercise Snacks in Chronic Disease Management: a Scoping Review [J]. Chinese General Practice, 2026, 29(30): 4472-4479. |
| [6] | CHEN Yujing, WANG Yan, LI Guang, DONG Benchao, YANG Peichuan, MA Jianxiong. Digital Technologies in the Management of Sarcopenia among Older Adults in Asia: a Scoping Review [J]. Chinese General Practice, 2026, 29(29): 4200-4210. |
| [7] | XIE Xiaoyun, LIU Chenxi, LIU Yushu, ZHOU Yihan. Artificial Intelligence Research Practices in Primary Healthcare Institutions in China and the Potential Issue of Data Poverty: a Scoping Review [J]. Chinese General Practice, 2026, 29(28): 4067-4077. |
| [8] | FENG Yachen, LIU Lewei, XUE Jinyue, SUN Xianlin, LIU Huanzhong. Research Progress of Wearable Technology in the Diagnosis and Treatment of Mental Disorders [J]. Chinese General Practice, 2026, 29(27): 4016-4025. |
| [9] | LIU Yahui, XU Yanan, YUAN Ling, WU Ligui, ZHOU Yujie, KANG Yubiao. A Scoping Review on Triage for Palliative Care Patients Based on Priority Decision-making [J]. Chinese General Practice, 2026, 29(24): 3538-3544. |
| [10] | WANG Rui, LUO Shuoming, YANG Liang, WANG Peng, ZHAO Yang, WANG Qi, ZHOU Zhiguang. Diabetes Prevalence among Older Adults in China: a Systematic Review and Meta-analysis [J]. Chinese General Practice, 2026, 29(24): 3500-3508. |
| [11] | WU Liyun, SUN Huajing, GU Yiqing, MEI Ziqi, JIN Shengji, ZHANG Suju, ZHU Yun, ZHANG Yao, LI Qin, LIU Xiaomiao, WANG Qing, BAI Yamei, XU Guihua. Application of Digital-intelligent Technology in Electrocardiographic Monitoring for Acute Myocardial Infarction: a Scoping Review [J]. Chinese General Practice, 2026, 29(24): 3545-3552. |
| [12] | WU Ermei, SUN Dajuan, DENG Hualiang. A Review of Role of miRNA in Ulcerative Colitis and Traditional Chinese Medicine Intervention [J]. Chinese General Practice, 2026, 29(23): 3371-3378. |
| [13] | WANG Longyu, LI Ya, MA Qian, JIA Peilin, ZHANG Hailong. Clinical Application Progress of Diffusing Capacity of the Lung for Carbon Monoxide in Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2026, 29(23): 3379-3384. |
| [14] | RUAN Hejing, ZHAO Wen, LI Longcan, ZHAO Jiufa, LI Dongdong. The Non-canonical Functions and Therapeutic Prospects of Parkin in Metabolic Associated Fatty Liver Disease [J]. Chinese General Practice, 2026, 29(23): 3268-3274. |
| [15] | FENG Yuxi, WANG Jinjin, CAI Yi, ZHU Runzhi, ZHU Qin. Research Progress on Protein Lactylation in Kidney Diseases [J]. Chinese General Practice, 2026, 29(21): 3056-3063. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||